JFG
ATOS icon

Jefferies Financial Group’s Atossa Therapeutics ATOS Stock Holding History

Jefferies Financial Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,547
Closed -$68.8K – 1406
2024
Q1 		$68.8K Buy
+2,547
New +$40.9K ﹤0.01% 1476

Other funds holding ATOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jefferies Financial Group's ATOS Position: Q2 2024 in Review

Jefferies Financial Group sold out of Atossa Therapeutics (ATOS) in Q2 2024, closing a stake of 2,547 shares — an estimated $68.8K sold.

Jefferies Financial Group first reported a position in ATOS in Q1 2024 and held it in 1 quarter. The position peaked at $68.8K in Q1 2024. 77 funds tracked by Wall St. Rank hold ATOS as of Q2 2024.

  • Jefferies Financial Group reported no remaining Atossa Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 2,547 Atossa Therapeutics shares in Q2 2024, an estimated $68.8K.
  • Jefferies Financial Group first reported a position in Atossa Therapeutics in Q1 2024 and held it in 1 quarter.
  • Jefferies Financial Group's Atossa Therapeutics position peaked at $68.8K in Q1 2024.
  • 77 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.